• Measure Summary
  • NQMC:006375
  • 2009 Jun

Pancreatic cancer: percentage of patients undergoing cancer-directed resection for whom the tumor histology is recorded.

American College of Surgeons

  • Measure Summary
  • NQMC:007191
  • 2009 Nov

Melanoma: percentage of patients with a melanoma less than or equal to 1 mm thick (i.e., T1) for whom the surgical excision margins are 1 cm (or the specific anatomic or cosmetic factors that limit margin distance are noted).

American College of Surgeons

  • Measure Summary
  • NQMC:011069
  • 2016 Jun

Bladder cancer: proportion of patients with muscle invasive bladder cancer (MIBC) who are discussed at the multidisciplinary team (MDT) meeting before definitive treatment.

NHS Scotland; Scottish Cancer Taskforce

  • Measure Summary
  • NQMC:007211
  • 2009 Nov

Melanoma: percentage of patients with melanoma who have biopsy-proven, palpable nodal disease who do not undergo sentinel lymph node biopsy (SLNB).

American College of Surgeons

  • Measure Summary
  • NQMC:007188
  • 2009 Nov

Melanoma: percentage of patients with a melanoma in situ (i.e., Tis) for whom the surgical excision margins are 5 mm (or the specific anatomic or cosmetic factors that limit margin distance are noted).

American College of Surgeons

  • Measure Summary
  • NQMC:006378
  • 2009 Jun

Pancreatic cancer: percentage of patients undergoing cancer-directed resection for whom the margin status is recorded.

American College of Surgeons

  • Measure Summary
  • NQMC:007194
  • 2009 Nov

Melanoma: percentage of patients to undergo a sentinel lymph node biopsy (SLNB) for melanoma for whom lymphoscintigraphy is performed to identify the draining nodal basin(s) when drainage to more than one basin is possible.

American College of Surgeons

  • Measure Summary
  • NQMC:007402
  • 2010 Jun

Breast cancer: the proportion of patients with breast cancer (invasive or in situ) who had a pre-operative definitive diagnosis (B5 or C5).

European Society of Breast Cancer Specialists

  • Measure Summary
  • NQMC:006401
  • 2009 Jun

Pancreatic cancer: percentage of patients undergoing resection for whom the surgeon documents intraoperative findings in the operative note including the absence of 1) regional arterial involvement, 2) metastatic disease (liver, peritoneal, omental), and 3) distant adenopathy.

American College of Surgeons

  • Measure Summary
  • NQMC:011199
  • 2016 Jul

Prostate cancer: proportion of patients with non-metastatic prostate cancer (TanyNanyM0) discussed at the multidisciplinary team (MDT) meeting before definitive treatment.

NHS Scotland; Scottish Cancer Taskforce

  • Measure Summary
  • NQMC:007200
  • 2009 Nov

Melanoma: percentage of patients who undergo an axillary lymph node dissection (LND) or completion lymph node dissection (CLND) for melanoma for whom at least 10 regional lymph nodes are resected and pathologically examined.

American College of Surgeons

  • Measure Summary
  • NQMC:011163
  • 2015 Jan

Upper gastrointestinal (GI) cancer: proportion of patients with oesophageal or gastric cancer who have tumour node metastases (TNM) stage and treatment intent recorded at a multidisciplinary team (MDT) meeting prior to treatment.

NHS Scotland; Scottish Cancer Taskforce

  • Measure Summary
  • NQMC:006384
  • 2009 Jun

Pancreatic cancer: percentage of patients undergoing resection for whom the College of American Pathologists checklist or equivalent reporting system is followed and fully documented.

American College of Surgeons

  • Measure Summary
  • NQMC:006381
  • 2009 Jun

Pancreatic cancer: percentage of patients undergoing resection of a pancreatic head lesion for whom the surgeon documents complete removal of all pancreatic tissue, lymph nodes, and connective tissue between the edge of the uncinate process and the right lateral wall of the superior mesenteric artery in the operative note.

American College of Surgeons

  • Measure Summary
  • NQMC:011087
  • 2016 Jan

Brain and central nervous system (CNS) cancer: proportion of patients with brain/CNS cancer who are discussed at the multidisciplinary team (MDT) meeting before definitive management.

NHS Scotland; Scottish Cancer Taskforce

  • Measure Summary
  • NQMC:007197
  • 2009 Nov

Melanoma: percentage of patients who have a stage Ib or II melanoma with whom sentinel lymph node biopsy (SLNB) is discussed.

American College of Surgeons

  • Measure Summary
  • NQMC:007405
  • 2010 Jun

Breast cancer: the proportion of patients (invasive cancer only) who received a single (breast) operation for the primary tumour (excluding reconstruction).

European Society of Breast Cancer Specialists

  • Measure Summary
  • NQMC:005609
  • 2009 Aug
  • NQF-Endorsed Measure

Language services: the percent of patient visits and admissions where preferred spoken language for health care is screened and recorded.

Center for Health Care Quality, Department of Health Policy, George Washington University School of Public Health and Health Services

  • Measure Summary
  • NQMC:006387
  • 2009 Jun

Pancreatic cancer: percentage of patients undergoing cancer-directed resection for whom adjuvant chemotherapy with or without radiation is considered or administered, or a valid reason is documented for not receiving adjuvant therapy.

American College of Surgeons

  • Measure Summary
  • NQMC:007408
  • 2010 Jun

Breast cancer: the proportion of patients with invasive breast cancer (M0) who received post-operative radiotherapy after surgical resection of the primary tumour and appropriate axillary staging/surgery in the framework of BCT.

European Society of Breast Cancer Specialists